Unity Biotechnology, Inc. Operating Lease, Liability, Noncurrent
Unity Biotechnology, Inc. had Operating Lease, Liability, Noncurrent of $18.68 million as of 2025-03-31, per its 10-Q filed 2025-04-22.
Financial Statements › Balance Sheet › Liabilities
us-gaap:OperatingLeaseLiabilityNoncurrent · last filed 2025-04-22
- 2025-03-31: Operating Lease, Liability, Noncurrent $18.68M.
- 2024-12-31: Operating Lease, Liability, Noncurrent $19.71M.
- 2024-09-30: Operating Lease, Liability, Noncurrent $20.70M.
- 2024-06-30: Operating Lease, Liability, Noncurrent $21.66M.
| Period end | Operating Lease, Liability, Noncurrent |
|---|---|
| 2025-03-31 | $18.68M 10-Q · filed 2025-04-22 |
| 2024-12-31 | $19.71M 10-Q · filed 2025-04-22 |
| 2024-09-30 | $20.70M 10-Q · filed 2024-11-04 |
| 2024-06-30 | $21.66M 10-Q · filed 2024-08-06 |
| 2024-03-31 | $22.61M 10-Q · filed 2024-05-14 |
| 2023-12-31 | $23.54M 10-K · filed 2025-03-07 |
| 2023-09-30 | $24.43M 10-K · filed 2024-04-15 |
| 2023-06-30 | $25.30M 10-K · filed 2024-04-15 |
| 2023-03-31 | $26.15M 10-K · filed 2024-04-15 |
| 2022-12-31 | $26.99M 10-K · filed 2024-04-15 |
| 2022-09-30 | $27.79M 10-K · filed 2024-04-15 |
| 2022-06-30 | $28.57M 10-Q · filed 2022-08-12 |
| 2022-03-31 | $29.34M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $30.09M 10-K · filed 2023-03-15 |
| 2021-09-30 | $30.81M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $32.04M 10-Q · filed 2021-08-10 |
| 2021-03-31 | $33.26M 10-Q · filed 2021-05-11 |
| 2020-12-31 | $34.47M 10-K · filed 2022-03-15 |
| 2020-09-30 | $35.63M 10-Q · filed 2020-11-04 |
| 2020-06-30 | $36.77M 10-Q · filed 2020-07-31 |
| 2020-03-31 | $37.89M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $0.00 10-K · filed 2021-03-23 |